Glaukos Corporation is an ophthalmic medical technology and pharmaceutical company focused on developing and commercializing novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. Founded in 1998 and headqua…
HQ: Aliso Viejo, CA, United States of Americawww.glaukos.com
USD167.25-1.84%vs prev. close
Market snapshot
Price
USD167.25
Daily move
-1.84%
P/E
—
EPS TTM
-3.28
Dividend yield
—
Beta
0.77
Market cap
9.9B
Price history
GKOS price
USD
No price history available
Next earnings
No upcoming earnings report scheduled in the next 6 months.
Peer comparison
Company
Ticker
Industry
Mkt cap (USD bn)
P/E
Div yld
1W
1M
3M
6M
1Y
YTD
Glaukos
GKOS
Medical Devices
9.9
—
—
-5.8%
-10.4%
+31.9%
+72.4%
+91.2%
+48.1%
🔒
Subscribe to Equity Analytics to compare GKOS with its closest peers
Sector-matched peer set with side-by-side valuation, dividend and performance over every window.